T 0902/07 (BRCA2/CANCER RESEARCH TECHNOLOGY) of 7.9.2010

European Case Law Identifier: ECLI:EP:BA:2010:T090207.20100907
Date of decision: 07 September 2010
Case number: T 0902/07
Application number: 96939218.2
IPC class: C07K 14/82
Language of proceedings: EN
Distribution: D
Download and more information:
Decision text in EN (PDF, 136 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: Materials and methods relating to the identification and sequencing of the BRCA2 cancer susceptibility gene and uses thereof
Applicant name: Cancer Research Technology Limited, et al
Opponent name: Myriad Genetics, Inc.
Board: 3.3.04
Headnote: -
Relevant legal provisions:
European Patent Convention Art 54
European Patent Convention Art 87
European Patent Convention Art 88
European Patent Convention Art 89
Rules of procedure of the Boards of Appeal Art 15
Keywords: Main request, auxiliary requests 1-5, priority - (no), novelty (no)
Change of date of oral proceedings - (yes)
Catchwords:

-

Cited decisions:
G 0002/98
T 0073/88
T 0923/92
T 1213/05
T 0699/06
Citing decisions:
-

Source: http://www.epo.org/law-practice/case-law-appeals/recent/t070902eu1.html

Date retrieved: 17 May 2021

10 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

Case Law Book: III Amendments

Case Law of the Enlarged Board

General Case Law